We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
George King

George L. King MD

Chief Scientific Officer and Head, Section of Vascular Cell Biology, Joslin Diabetes Center; Professor of Medicine and Ophthalmology, Harvard Medical School, Boston, Massachusetts
Dr. King is the Senior Vice President, Chief Scientific Officer, and Founder/Director of the AADI at Joslin Diabetes Center, as well as a Professor of Medicine and Ophthalmology at Harvard Medical School. Dr. King is an endocrinologist with research focus on vascular complications of diabetes and diabetes in Asian-Americans.

Disclosures

Dr. King has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. CV Effects of SGLT2is and GLP-1RAs in Asians vs Whites